EVMN — Evommune Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual balance sheet for Evommune, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	79.1	72	149
Prepaid Expenses
Total Current Assets	80	74	153
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.97	1.8	2.46
Long Term Investments
Other Long Term Assets
Total Assets	82.2	76.1	225
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6.86	28	17.9
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	10.6	28.5	19.4
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	71.7	47.5	206
Total Liabilities & Shareholders' Equity	82.2	76.1	225
Total Common Shares Outstanding